Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 100, Number 5, 1 May 2018

Risk‐adapted GVHD prophylaxis with post‐transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations
pp. 395-402(8)
Authors: Moiseev, Ivan S.; Pirogova, Olga V.; Alyanski, Alexandr L.; Babenko, Elena V.; Gindina, Tatyana L.; Darskaya, Elena I.; Slesarchuk, Olga A.; Bykova, Tatyana A.; Chukhlovin, Alexei B.; Pevtcov, Dmitrii E.; Bondarenko, Sergey N.; Afanasyev, Boris V.

Favourites:
ADD

Low plasma protein Z levels are associated with an increased risk for perioperative bleedings
pp. 403-411(9)
Authors: Hinterleitner, Clemens; Kreisselmeier, Klaus‐Peter; Pecher, Ann‐Christin; Mauz, Paul‐Stefan; Kanz, Lothar; Kopp, Hans‐Georg; Jaschonek, Karl G.

Favourites:
ADD

Pretreatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP)
pp. 412-418(7)
Authors: Essilini, Anaïs; Comont, Thibault; Germain, Johanne; Brun, Natacha; Dingremont, Claire; Castel, Brice; Arista, Sophie; Madaule, Serge; Sailler, Laurent; Lapeyre‐Mestre, Maryse; Beyne‐Rauzy, Odile; Godeau, Bertrand; Adoue, Daniel; Moulis, Guillaume; the CARMEN investigators groupejh13032-cr-0015

Favourites:
ADD

Genetic variation in IL28B (IFNL3) and response to interferon‐alpha treatment in myeloproliferative neoplasms
pp. 419-425(7)
Authors: Lindgren, Marie; Samuelsson, Jan; Nilsson, Lars; Knutsen, Håvar; Ghanima, Waleed; Westin, Johan; Johansson, Peter L.; Andréasson, Björn

Favourites:
ADD

miRNA‐15a, miRNA‐16, miRNA‐126, miRNA‐146a, and miRNA‐223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment
pp. 426-435(10)
Authors: Nowicki, Mateusz; Szemraj, Janusz; Wierzbowska, Agnieszka; Misiewicz, Małgorzata; Małachowski, Roman; Pluta, Agnieszka; Grzybowska–Izydorczyk, Olga; Robak, Tadeusz; Szmigielska‐Kapłon, Anna

Favourites:
ADD

MLL‐rearranged acute myeloid leukemia: Influence of the genetic partner in allo‐HSCT response and prognostic factor of MLL 3′ region mRNA expression
pp. 436-443(8)
Authors: Burillo‐Sanz, Sergio; Morales‐Camacho, Rosario M.; Caballero‐Velázquez, Teresa; Carrillo, Estrella; Sánchez, Javier; Pérez‐López, Olga; Pérez de Soto, Inmaculada; González Campos, José; Prats‐Martín, Concepción; Bernal, Ricardo; Vargas, María Teresa

Favourites:
ADD

Chronic lymphoproliferative disorder of NK‐cells: A single‐institution review with emphasis on relative utility of multimodality diagnostic tools
pp. 444-454(11)
Authors: Kurt, Habibe; Jorgensen, Jeffrey L.; Amin, Hesham M.; Patel, Keyur P.; Wang, Sa A.; Lin, Pei; Kanagal‐Shamanna, Rashmi; Loghavi, Sanam; Thakral, Beenu; Khogeer, Haitham A.; Jabbour, Elias J.; Li, Shaoying; Yin, C. Cameron; Medeiros, L. Jeffrey; Khoury, Joseph D.

Favourites:
ADD

Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice
pp. 455-464(10)
Authors: Reiser, Marcel; Dörfel, Steffen; Hensel, Manfred; Hoesl, Mark; Jordan, Wolf‐Oliver; Koenigsmann, Michael; Meyer, Dirk; Reichert, Dietmar; Schwarzer, Andreas; Marquardt, Moritz; Kellershohn, Kerstin; Jentsch‐Ullrich, Kathleen

Favourites:
ADD

Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG ‐ CLL4 (ML21283) trial
pp. 465-474(10)
Authors: Robak, Tadeusz; Błoński, Jerzy; Skotnicki, Aleksander Bartłomiej; Piotrowska, Magdalena; Wróbel, Tomasz; Rybka, Justyna; Kłoczko, Janusz; Bołkun, Łukasz; Budziszewska, Bożena Katarzyna; Walczak, Urszula; Uss, Anatoly; Fidecka, Marta; Smolewski, Piotr

Favourites:
ADD

Thromboembolism prophylaxis in patients with Philadelphia‐negative myeloproliferative neoplasms—Clinical practice among Nordic specialists
pp. 475-478(4)
Authors: Bjerrum, Ole Weis; Samuelsson, Jan; Ghanima, Waleed; Kauppila, Marjut; Andersen, Christen Lykkegaard; the Nordic Myeloproliferative Neoplasm Study Groupejh13043-cr-0006

Favourites:
ADD

Healthcare resource utilisation associated with skeletal‐related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study
pp. 479-487(9)
Authors: Ashcroft, John; Duran, Ignacio; Hoefeler, Herbert; Lorusso, Vito; Lueftner, Diana; Campioni, Marco; Intorcia, Michele; Bahl, Amit

Favourites:
ADD
Favourites:
ADD

Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
pp. 494-501(8)
Authors: Pick, Marjorie; Vainstein, Vladimir; Goldschmidt, Neta; Lavie, David; Libster, Diana; Gural, Alexander; Grisariu, Sigal; Avni, Batia; Ben Yehuda, Dina; Gatt, Moshe E.

Favourites:
ADD

Bacterial neuraminidase‐mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure
pp. 502-510(9)
Authors: Qadri, Syed M.; Donkor, David A.; Nazy, Ishac; Branch, Donald R.; Sheffield, William P.

Favourites:
ADD

Expression pattern of PD‐L1 and PD‐L2 in classical Hodgkin lymphoma, primary mediastinal large B‐cell lymphoma, and gray zone lymphoma
pp. 511-517(7)
Authors: Tanaka, Yosuke; Maeshima, Akiko Miyagi; Nomoto, Junko; Makita, Shinichi; Fukuhara, Suguru; Munakata, Wataru; Maruyama, Dai; Tobinai, Kensei; Kobayashi, Yukio

Favourites:
ADD

Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma
pp. 518-525(8)
Authors: Gueneau, Pauline; Chretien, Marie‐Lorraine; Cransac‐Miet, Amelie; Aho, Ludwig Serge; Lafon, Ingrid; Favennec, Camille; Guy, Julien; Caillot, Denis; Boulin, Mathieu

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more